Zoetis
ZTS
#277
Rank
NZ$122.55 B
Marketcap
NZ$275.28
Share price
-0.46%
Change (1 day)
-5.67%
Change (1 year)

P/E ratio for Zoetis (ZTS)

P/E ratio as of June 2025 (TTM): 29.7

According to Zoetis's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 29.7168. At the end of 2024 the company had a P/E ratio of 29.7.

P/E ratio history for Zoetis from 2013 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202429.7-23.63%
202338.919.8%
202232.5-42.74%
202156.8
201942.145.36%
201829.0-29.16%
201740.926.17%
201632.4-53.96%
201570.589.97%
201437.114.61%
201332.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Eli Lilly
LLY
65.9 121.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
11.7-60.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
17.6-40.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Phibro Animal Health
PAHC
24.8-16.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Kindred Biosciences
KIN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Heska Corporation
HSKA
-62.2-309.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
17.5-40.98%๐Ÿ‡ซ๐Ÿ‡ท France

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.

OSZAR »